These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35071359)

  • 1. The Complex Interplay of Inflammation, Metabolism, Epigenetics, and Sex in Calcific Disease of the Aortic Valve.
    Ferrari S; Pesce M
    Front Cardiovasc Med; 2021; 8():791646. PubMed ID: 35071359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcific Aortic Valve Disease-Natural History and Future Therapeutic Strategies.
    Alushi B; Curini L; Christopher MR; Grubitzch H; Landmesser U; Amedei A; Lauten A
    Front Pharmacol; 2020; 11():685. PubMed ID: 32477143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular aspects of calcific aortic valve disease.
    Towler DA
    Circ Res; 2013 Jul; 113(2):198-208. PubMed ID: 23833294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification.
    Vieceli Dalla Sega F; Fortini F; Cimaglia P; Marracino L; Tonet E; Antonucci A; Moscarelli M; Campo G; Rizzo P; Ferrari R
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease.
    Cho KI; Sakuma I; Sohn IS; Jo SH; Koh KK
    Atherosclerosis; 2018 Oct; 277():60-65. PubMed ID: 30173080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets.
    Hulin A; Hego A; Lancellotti P; Oury C
    Front Cardiovasc Med; 2018; 5():21. PubMed ID: 29594151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting vasoactive peptides for managing calcific aortic valve disease.
    Peltonen T; Ohukainen P; Ruskoaho H; Rysä J
    Ann Med; 2017 Feb; 49(1):63-74. PubMed ID: 27585243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of inflammatory responses in the early development of calcific aortic valve disease: lessons from statin therapy.
    Lee SH; Choi JH
    Anim Cells Syst (Seoul); 2018; 22(6):390-399. PubMed ID: 30533261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Specific Features of Calcific Aortic Valve Disease.
    Summerhill VI; Moschetta D; Orekhov AN; Poggio P; Myasoedova VA
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Andrographolide ameliorates aortic valve calcification by regulation of lipid biosynthesis and glycerolipid metabolism targeting MGLL expression in vitro and in vivo.
    Wang C; Huang Y; Liu X; Li L; Xu H; Dong N; Xu K
    Cell Calcium; 2021 Dec; 100():102495. PubMed ID: 34740021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Glucagon-Like Peptide-1 Is Associated With Calcific Aortic Valve Disease: GLP-1 Suppresses the Calcification of Aortic Valve Interstitial Cells.
    Xiao F; Zha Q; Zhang Q; Wu Q; Chen Z; Yang Y; Yang K; Liu Y
    Front Cardiovasc Med; 2021; 8():709741. PubMed ID: 34513952
    [No Abstract]   [Full Text] [Related]  

  • 12. Label-free optical biomarkers detect early calcific aortic valve disease in a wild-type mouse model.
    Tandon I; Johns S; Woessner A; Perez J; Cross D; Ozkizilcik A; Muldoon TJ; Vallurupalli S; Padala M; Quinn KP; Balachandran K
    BMC Cardiovasc Disord; 2020 Dec; 20(1):521. PubMed ID: 33308143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Label-Free Multiphoton Microscopy for the Detection and Monitoring of Calcific Aortic Valve Disease.
    Tandon I; Quinn KP; Balachandran K
    Front Cardiovasc Med; 2021; 8():688513. PubMed ID: 34179147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.
    Pasipoularides A
    J Cardiovasc Transl Res; 2016 Apr; 9(2):102-18. PubMed ID: 26891845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.
    van der Ven CF; Wu PJ; Tibbitt MW; van Mil A; Sluijter JP; Langer R; Aikawa E
    Clin Sci (Lond); 2017 Feb; 131(3):181-195. PubMed ID: 28057890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pharmacological targets for calcific aortic valve disease: Prevention and treatments.
    Myasoedova VA; Ravani AL; Frigerio B; Valerio V; Moschetta D; Songia P; Poggio P
    Pharmacol Res; 2018 Oct; 136():74-82. PubMed ID: 30149054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of altered mechanobiology on aortic valve pathophysiology.
    Bardon KM; Garelnabi M
    Arch Biochem Biophys; 2020 Sep; 691():108463. PubMed ID: 32590066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus.
    Mosch J; Gleissner CA; Body S; Aikawa E
    Histol Histopathol; 2017 Mar; 32(3):293-306. PubMed ID: 27353274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops.
    Li C; Xu S; Gotlieb AI
    Cardiovasc Pathol; 2013; 22(1):1-8. PubMed ID: 22795219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFκB (Nuclear Factor κ-Light-Chain Enhancer of Activated B Cells) Activity Regulates Cell-Type-Specific and Context-Specific Susceptibility to Calcification in the Aortic Valve.
    Gee T; Farrar E; Wang Y; Wu B; Hsu K; Zhou B; Butcher J
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):638-655. PubMed ID: 31893948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.